Skip to content
Screener

908 Devices MASS Business Segments — Cost Of Revenue

Similar metrics at other companies

Vuzix logo
VUZISingle Reportable — Cost Of Revenue
$1.34M-4.7%
Pulse Biosciences, Inc. logo
PLSESingle Reportable — Cost Of Revenue
$245K
PDF Solutions logo
PDFSSingle Reportable — Cost Of Revenue
$19.11M+28.4%
Iovance Biotherapeutics, Inc. logo
IOVASingle Reportable — Cost Of Revenue
$43.6M-10.8%
Monarch Casino & Resort logo
MCRISingle Reportable — Cost Of Revenue
$11.61M+6.2%
Wrap Technologies logo
WRAPSingle Reportable — Cost Of Revenue
$507K-3.4%

Other financials

Income statement

See full
Revenue$16.1M+23.3%
Gross profit$8.3M+30.9%
Operating income-$12.8M+15.5%
Net income-$11.9M+10.6%
EPS (diluted)-$0.32+13.5%

Balance sheet

See full
Cash & equivalents$63.0M+2.1%
Total debt$4.3M-3.0%
Total equity$126.8M-14.8%
Total assets$197.5M+3.0%

Cash flow

See full
Operating cash flow$3.2M+155%
CapEx$162.0K+32.8%
Free cash flow$3.0M+151%

Valuation

See full
Market cap$361.04M+55.6%
Enterprise value$302.32M+73.0%
P/S5.9×+1.6×

Profitability

See full
Gross margin52.2%+3.0pp
Operating margin-69.1%-21.4pp
Net margin-57%+109pp
FCF margin-1.2%-0.6pp

Returns & leverage

See full
Return on equity-25.2%-336pp
Debt / equity0.0×
Current ratio2.7×-2.3×

Where this comes from

Reported directly by 908 Devices in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The source filing: 908 Devices’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 7:20 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-093731
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Cost of revenue:
Product cost of revenue6,4125,32311,57310,048
Service and contract cost of revenue1,3191,3392,6582,850
Total cost of revenue7,7316,66214,23112,898
Gross profit8,3436,37315,22511,915
Operating expenses:
Research and development3,5984,4057,0698,234
Selling, general and administrative11,11210,33721,02720,576

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is 908 Devices's business segments — cost of revenue?
908 Devices (MASS) reported business segments — cost of revenue of $7.73M in Q2 2026.
How has 908 Devices's business segments — cost of revenue changed year-over-year?
908 Devices's business segments — cost of revenue increased by 16.0% year-over-year, from $6.66M to $7.73M.
What is the long-term trend for 908 Devices's business segments — cost of revenue?
Over 2 years (2023 to 2025), 908 Devices's business segments — cost of revenue has grown at a 5.6% compound annual growth rate (CAGR), from $24.91M to $27.77M.
What does business segments — cost of revenue mean?
This metric captures the direct costs incurred to manufacture and deliver the company's mass spectrometry devices, including materials, labor, and overhead directly attributable to production. Monitoring this allows investors to assess the efficiency of the company's supply chain and production processes. High costs relative to revenue may indicate challenges in manufacturing scalability or pricing pressure.

Ask your AI about 908 Devices's business segments — cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude